Anthony A. Estrada
Rapt Therapeutics (United States)(US)Denali Therapeutics (United States)(US)Tetra Therapeutics (United States)(US)Sunesis (United States)(US)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Microbial Natural Products and Biosynthesis, Endoplasmic Reticulum Stress and Disease, Asymmetric Synthesis and Catalysis, RNA regulation and disease
Most-Cited Works
- → Ser 1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations(2012)373 cited
- → A Mild and Selective Method for the Hydrolysis of Esters with Trimethyltin Hydroxide(2005)369 cited
- → Effect of selective LRRK2 kinase inhibition on nonhuman primate lung(2015)364 cited
- → Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease(2022)237 cited
- → Recent Advances in the Chemistry and Biology of Naturally Occurring Antibiotics(2009)223 cited
- → Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors(2012)161 cited